Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 13.03 | N/A |
| PEG Ratio (TTM) | 1.87 | N/A |
| P/S Ratio (TTM) | 2.94 | N/A |
| P/B Ratio (TTM) | 5.84 | N/A |
| P/FCF Ratio (TTM) | 13.30 | N/A |
| Price to 5YR AVG Earnings Ratio | 22.07 | N/A |
| Price to 5YR AVG FCF Ratio | 17.25 | N/A |
Profitability (85%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 13.53% | N/A |
| ROE (TTM) | 51.13% | N/A |
| Net Profit Margin (TTM) | 22.66% | N/A |
| ROIC 5YR AVG | 22.49% | N/A |
Growth (48%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 7.00% | 4.49% | 16.53% |
| Revenue | 2.88% | -2.67% | 3.38% |
| Net Income | 6.15% | -2.72% | 7.75% |
| Cash Flow | 6.91% | -6.46% | 0.68% |
Health (79%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.83 | N/A |
| Quick Ratio (TTM) | 2.25 | N/A |
| D/E Ratio (TTM) | 1.48 | N/A |
| Interest Coverage (TTM) | 10.23 | N/A |
| Piotroski F-Score | 9 | N/A |
| Altman Z-Score | 2.87 | N/A |
| LTL to 5YR AVG FCF | 4.60 | N/A |
| Shares Outstanding Growth 5YR AVG | -7.48% | N/A |